Secretion of sHLA-G molecules in malignancies
- 19 September 2003
- journal article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (5) , 371-377
- https://doi.org/10.1016/s1044-579x(03)00028-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapyCancer, 2001
- A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-βJournal of Biological Chemistry, 2001
- HLA‐G has a concentration‐dependent effect on the generation of an allo‐CTL responseImmunology, 2000
- Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanomaThe Lancet, 2000
- Melanomas and melanoma cell lines do not express HLA‐G, and the expression cannot be induced by γIFN treatmentTissue Antigens, 2000
- Mini symposium. The major histocompatibility complex in pregnancy: Part II. Placental HLA-G protein expression in vivo: where and what for?Human Reproduction Update, 1999
- Detection of soluble HLA‐G molecules in plasma and amniotic fluidTissue Antigens, 1999
- HLA‐G Polymorphisms: Ethnic Differences and Implications for Potential Molecule FunctionAmerican Journal of Reproductive Immunology, 1998
- The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP associationImmunity, 1995